- J&J multiple myeloma drug gains edge in earlier stage disease<figure><div><img src="https://imgproxy.divecdn.com/cm_W-FdbiM9BbB0zoOGzQIxUTIYDjzY9Hg-zhECEdaE/g:nowe:208:253/c:1738:982/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS85MzMxNjUxLWZh…BioPharma Dive · 1mo ago↗ source
- Lilly puts its stamp at #EHA26 with Jaypirca combo data in CLL, first clinical data from Ajax buyoutEli Lilly made a push in blood cancer at this year’s European Hematology Association meeting in Stockholm over the weekend. The drugmaker presented data for Jaypirca combined with the standard of…Endpoints · 1mo ago↗ source
- Celiac disease is entering a new era of therapeutic innovation<p>For the ~1 in 100 people living with celiac, the burden of disease extends far beyond their plate.</p>